How Innovative Therapies are Reshaping the Idiopathic Pulmonary Fibrosis Treatment Market
The Idiopathic Pulmonary Fibrosis (IPF) Treatment Market is witnessing a remarkable transformation, characterized by a projected market size increase from USD 3.89 billion in 2024 to USD 7.963 billion by 2035. This represents a robust compound annual growth rate (CAGR) of 6.73%. As patient demand surges, driven by a higher prevalence of IPF and advancements in diagnostic technologies,...
0 Condivisioni
28 Visualizzazioni